10 Best Medical Imaging Tools in 2026

Viz.ai is an AI-powered care coordination platform designed to transform patient care by accelerating diagnosis and streamlining treatment decisions. It utilizes over 50 FDA-cleared AI algorithms to analyze medical imaging data (CT scans, EKGs, echocardiograms, etc.), delivering real-time insights and automated assessments. The platform aims to close gaps between patients, clinicians, and life-saving treatments across various therapeutic areas including neurovascular, cardiovascular, vascular, trauma, and radiology. Viz.ai One, the core solution, provides an all-in-one platform that auto-detects suspected diseases in seconds, enabling faster time to diagnosis and treatment. It facilitates real-time communication among multidisciplinary care teams via mobile and desktop devices, ensuring patients receive timely and appropriate care. The platform is clinically validated with over 100 publications and abstracts, trusted by over 1,800 hospitals, and integrates seamlessly with EHR and PACS solutions. It also partners with pharmaceutical and medical device companies to develop customized solutions for treatable diseases, enhancing patient access and adherence to treatments.

Path AI develops AI-powered pathology technology that improves diagnostic accuracy in healthcare. Pathologists receive AI assistance analyzing tissue samples for cancer and other diseases. The platform accelerates diagnosis and supports clinical research.

PathAI is a leading AI-powered pathology platform dedicated to improving patient outcomes through reliable technology and collaboration with biopharma and pathology laboratories. Its core offering, AISight, is a cloud-native intelligent enterprise workflow solution that serves as a central hub for case management, image management, and best-in-class artificial intelligence tools for histopathology use cases. AISight is designed to power digital pathology workflows and AI applications for academic medical centers, reference laboratories, health systems, and biopharma. The platform provides invaluable insights for biomarker discovery, drug development, and improved laboratory workflows. PathAI offers a robust AI product menu with specialized algorithms for oncology, MASH (Metabolic Dysfunction-Associated Steatohepatitis), Inflammatory Bowel Disease, and Celiac disease, enabling quantitative analysis of pathology images. These AI tools assist pathologists in various tasks, from automated scoring and biomarker quantification to case prioritization and quality control, ultimately driving precision medicine forward.

RapidAI is a clinical AI platform designed to enhance medical assessment and transform patient care across various disease states. It leverages deep clinical AI to provide decision support for healthcare professionals, aiming to improve patient outcomes, drive operational efficiency, and strengthen financial viability for healthcare providers. The platform offers cutting-edge solutions for neurovascular conditions (stroke, trauma, aneurysm), cardiac & vascular issues (pulmonary embolism, aortic disease), and radiology workflows. It provides real-time insights, automates key metrics, and facilitates cross-disciplinary collaboration through its enterprise platform and mobile app. RapidAI is built on extensive clinical validation, with numerous publications and trials supporting its efficacy.

Proscia offers a comprehensive digital pathology platform, Concentriq, designed to transform pathology workflows from research and development to clinical diagnostics. It provides purpose-built solutions for life sciences (Concentriq LS) to accelerate biomarker discovery and drug development, and for diagnostics (Concentriq AP and FDA-cleared Concentriq AP-Dx) to digitize labs, improve diagnostic quality, and increase efficiency. The platform integrates advanced digitization, AI, and real-world data to enable faster breakthroughs and more precise patient insights. The platform is utilized by leading academic medical centers, health systems, commercial labs, major CROs, and pharmaceutical companies. Proscia's solutions aim to address challenges like the rising diagnostic burden, pathologist shortages, and the increasing demand for precision medicine by offering intuitive interfaces for interpreting and managing cases, advanced collaboration tools, and AI-powered image analysis. Proscia Aperture, a precision medicine solution, further enhances the platform by turning routine pathology data into actionable, real-time insights, supporting drug development and market access strategies. Proscia's offerings are designed to accelerate the shift to 100% digital diagnosis, empower data science and AI teams, and enable the development and deployment of AI solutions for both therapy development and precision diagnostics. It focuses on improving the pathologist experience, running more efficient labs, and positioning organizations for future growth in the evolving landscape of digital pathology and AI.

Lunit provides cutting-edge AI software designed to transform cancer care from early detection to precision oncology. The platform leverages artificial intelligence to analyze complex clinical data, including medical images and pathology slides, to deliver actionable insights for healthcare professionals. This enables earlier and more accurate cancer detection, streamlines screening workflows, and supports confident clinical decisions. The product suite is divided into two main areas: Cancer Screening and Precision Oncology. For screening, Lunit offers AI solutions like Lunit INSIGHT MMG (2D mammography) and Lunit INSIGHT DBT (3D tomosynthesis) to improve detection rates and efficiency. In precision oncology, Lunit SCOPE products analyze biomarkers and assist in companion diagnostics, accelerating drug development and clinical trials. The platform is built on world-class, diverse datasets, is clinically validated with FDA clearance and CE marks, and is designed for seamless integration into existing healthcare workflows, serving over 10,000 customer sites in 65+ countries.

Deep Bio develops AI software, primarily its DeepDx® suite, to assist medical professionals in cancer pathology diagnostics. The platform analyzes whole-slide images of tissue specimens to detect cancer, score its severity (e.g., Gleason scores for prostate cancer), and quantify specific biomarkers. By integrating state-of-the-art deep learning technology, Deep Bio aims to improve the accuracy, consistency, and reproducibility of diagnoses, addressing challenges like pathologist shortages and diagnostic variability. The DeepDx® solutions are designed for various cancer types, including prostate and breast cancer, and provide metrics that are difficult to measure manually. This allows clinicians to optimize treatment decisions and enhance patient care. The company also offers DeepCDx™, an AI-enabled drug discovery solution to guide biopharmaceutical companies in developing new drugs by leveraging data and AI for diagnostic solutions.

Aidoc provides an "Always On" AI platform, aiOS™, that integrates into healthcare systems to enhance clinical workflows and patient management. It offers AI-powered solutions across various medical specialties like Radiology, Vascular, Neuro, and Cardiology, aiming to improve patient care and clinical outcomes through rapid triage, notification, and seamless team collaboration. The platform helps medical professionals operationalize unexpected findings, assist with patient capture and follow-up, and reduce disruptions in the continuum of care. Specifically for radiology, Aidoc's AI medical imaging platform streamlines workflows for radiologists by prioritizing findings, activating care teams, and facilitating patient follow-up. It integrates deeply with existing EHR, PACS, Scheduling, and Reporting systems. The Aidoc Widget consolidates AI results from various algorithms into a single, unified interface, reducing cognitive burden and enhancing efficiency for radiologists. The platform offers a broad range of FDA-cleared and CE/UKCA-marked algorithms for detecting and quantifying pathologies across neurovascular, aortic, cardiology, chest, and abdomen imaging.